meRfi®-GM
Mucins & O-Glycans / O-Linked Glycosylation
Welcome to meRfi-GM!
meRfi-GM provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
Navigation
Contents
Aberrant glycosylation creates novel cancer-specific glycoantigens that can interact with cells of the immune system via carbohydrate-binding lectins
Mucin-like O-glycan structures are characteristic of numerous types of human tumor cells
see also:
Cancer & Glycosylation
…
References (Sources)
- Mucin-type O-glycans in human colon and breast cancer: glycodynamics and functions
- Protein glycosylation in cancer
- The Breast Cancer-Associated Glycoforms of MUC1, MUC1-Tn and sialyl-Tn Are Expressed in COSMC Wild-Type Cells and Bind the C-Type Lectin MGL
- The Study of Immunological Component in AntiTumor Effect of Trypanosoma Cruzi